Hepatitis c study explores link to rare blood cell changes
NCT ID NCT06564051
First seen Jan 07, 2026 · Last updated May 15, 2026 · Updated 20 times
Summary
This study aimed to find out how often people with chronic hepatitis C have a blood condition called monoclonal B-cell lymphocytosis (MBL) and whether treating hepatitis C affects MBL. Researchers collected blood samples from 29 participants before, during, and after hepatitis C treatment and compared them to samples from people without hepatitis C. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONOCLONAL B-CELL LYMPHOCYTOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.